Phathom Pharmaceuticals (PHAT) Change in Inventory (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Change in Inventory for 4 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Inventory rose 113.84% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $894000.0 (down 95.57% YoY), while the FY2025 annual figure was $11.8 million, up 91.81% from the prior year.
• Change in Inventory advanced to $4.0 million in Q2 2026 per PHAT's latest filing, from -$665000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $12.3 million in Q1 2025 and bottomed at -$2.0 million in Q4 2025.
• Historically, Change in Inventory has averaged $2.6 million across 4 years, with a median of $417000.0 in 2024.
• On a YoY basis, Change in Inventory climbed as much as 2863.46% in 2025 and fell as far as 194.5% in 2025.
• Phathom Pharmaceuticals' Change in Inventory stood at $9.3 million in 2023, then sank by 40.24% to $5.6 million in 2024, then sank by 135.9% to -$2.0 million in 2025, then soared by 297.6% to $4.0 million in 2026.
• Business Quant data shows PHAT's Change in Inventory at $4.0 million in Q2 2026, -$665000.0 in Q1 2026, and -$2.0 million in Q4 2025.